Anti-Dopamine beta-hydroxylase (N-Term, human)

Dopamine beta-hydroxylase (DBH) catalyzes the conversion of dopamine to norepinephrine and serves as a marker of noradrenergic cells. DBH antibodies and antibodies for other markers of catecholamine biosynthesis are widely used as markers for dopaminergic and noradrenergic neurons in a variety of applications including depression, schizophrenia, Parkinson's disease, and drug abuse. The expression of DBH is also elevated during stress.Synonyms: DBH. Immunogen: peptide from the N-terminal region of human dopamine beta-hydroxylase (DBH). Formulation: (Request formulation change), Peptide affinity-purified antibody. Host: sheep. Applications: western blot. Origin: Animal/Sheep.